Sentence examples for global immunity from inspiring English sources

In addition to molecular mimicry, suggested mechanisms for EBV causing immune-mediated disease [ 12] include mistaken self [ 13], bystander damage surrounding EBV reactivation [ 14], immortalisation of B cells secreting self-reactive antibodies [ 15] and the resetting of the immune system to favour more active global immunity against, with correspondingly less tolerance to, antigens [ 16].

In progressive HIV-infection, interventions aimed at expanding CD8+ T cell activity in the early phase of infection, when CD4 and CD8 T cell function is relatively preserved, may be an effective approach to improving global immunity and preventing opportunistic infections in advanced phase of immune-deficiency.

It is pushing many other countries to sign similar deals, hoping that a web of such bilateral agreements, which it claims are sanctioned by an obscure provision of the treaty called Article 98, will in effect give Americans global immunity from the court's jurisdiction.

Rather, a precise function of DC could be targeted during the infection that would specifically impair HCV clearance without affecting global immunity.

Since the patients appear immunologically competent, major dysfunction of dendritic cells (DC) is not expected, rather a discrete DC function could be targeted by the virus without affecting global immunity.

To approximate the WPV prevalence and global immunity levels at T0 we run the model for a "burn in" period to begin the policy comparisons starting with initial conditions that approximate actual demographic profiles and exposure histories [ 47] (Additional file 1).

Global herd immunity produced by circulation of the C2 genotype may protect the European population from the spread of other subgenotypes (3 ).

With the relative global lack of immunity to the pandemic influenza A/H1N1/2009 virus that emerged in April 2009 as well as the sustained susceptibility to infection, rapid and accurate diagnostic assays are essential to detect this novel influenza A variant.

Interestingly, we found distinctively in CS-treated cells a global decrease of immunity-related proteins, degradative enzymes (such as MMP1, MMP2, and MMP3), and some ECM structural proteins (such as fibronectin (FN1) and chitinase-3-like protein 1 (CHI3L1)).

But new strains that jump from animals to humans can be even more devastating if the global population has no immunity to the virus.

The strain has not circulated in humans since 1968, so much of the global population has no immunity to the strain.